What's TassieDoc? Labor's government-run GP clinic solution explained
The wait to see a GP can be weeks long and the gap between the doctor's fee and what Medicare covers can be costly.
For some, it means taking fewer trips to the doctor. Delaying GP visits also places more pressure on the state's already overburdened hospital system.
Labor thinks it has the answer: TassieDoc.
The idea is so promising, the Liberals have even vowed to match it.
Tasmanian Labor is proposing to create five government-run GP clinics in health hubs across the state that bulk-bill.
The idea is that the state government would provide the clinic and consulting rooms, as well as paying the nursing and admin staff.
Instead of needing to own the practice, doctors would be contractors.
Labor says each clinic would have four full-time-equivalent GPs.
The hope is that by alleviating the cost burdens of staffing and the clinic itself, doctors would be able to charge patients the cost of the Medicare benefit.
It's inspired by the federal and state governments' Urgent Care Clinics (UCC).
Labor says it will result in 100,000 bulk-billed appointments per year.
To put it in perspective, data from the Australian Institute of Health and Welfare (AIHW) shows GPs in Tasmania provided 6.7 million appointments between June 2024 and May 2025.
The plan is also for the clinics to operate with extended hours, including evenings and weekends.
Labor's Clark candidate and health spokesperson Ella Haddad said the clinics would be run out of existing state-run health clinics such as the Glenorchy Health Centre.
"We'll provide the bricks and mortar, we'll provide the nursing and admin staff that will allow doctors to come in and do what they do best, which is provide care to their patients.
"Not every doctor wants to be a business owner or have to worry about hiring staff."
TassieDoc patients will be bulk-billed for visits, meaning there will be no out-of-pocket payment.
As an election promise, Labor says it will spend $5 million to fit out the new clinics, then $4 million a year to keep them running, and $2 million towards incentives for GPs to work at them.
It has yet to be costed by Treasury.
A UCC is simply that, a clinic for urgent situations, not regular GP check-ups or emergencies.
UCCs were created to try to deal with that middle ground so that only genuine emergencies end up presenting in emergency departments.
The other difference is the way they are run and funded.
UCCs are co-funded federal and state initiatives and are found across the country.
While Tasmanian Labor has been talking up what state and federal Labor can do when their powers combine, TassieDoc is not a partnership.
The "powered by Medicare" policy just takes advantage of the Albanese government's decision to triple the Medicare bulk-billing incentive for GPs.
Prime Minister Anthony Albanese did not even utter the words "TassieDoc" while standing alongside Labor Leader Dean Winter at a press conference on Tuesday, instead spruiking his government's many UCCs.
Within hours of Labor revealing their plan, the Liberals pledged to "open five new GP bulk-billing clinics", claiming they were already doing it and had just announced one the day before in Legana.
But that was a UCC.
The Liberals have suggested Labor is rebadging said clinics, but the models are different.
At a press conference on Tuesday, Premier Jeremy Rockliff said he would match Labor's promise "and more".
In a further statement, Liberal Franklin candidate and health spokesperson Jacquie Petrusma said the Liberals would "work with GPs on the best way of delivering additional GP services right around the state".
"Including five clinics under the TassieDoc model and other innovative ways to support existing GPs like in Legana and Bicheno," Ms Petrusma said.
That is where those $2 million in incentive payments come in.
Labor is hoping they will be able to attract and retain 150 new GPs to Tasmania.
There will be 100 payments worth $10,000 available for GPs working in urban areas, and 50 worth $20,000 for GPs in rural and regional communities.
The Liberals have their own incentive payments that are already in place, offering up $100,000 to mainland doctors who want to move to the state.
The Liberals have also been trying to boost the number of GPs through the single-employer training model, where the state government offers doctors a single contract for their entire traineeship.
"We have 200 GPs in training right now, so [it's] fully subscribed," Mr Rockliff said.
"One hundred and fifty GPs are being supervised in regional clinics, [with] 40 of those fully qualified by the end of the year."
Standing with Labor at the first very TassieDoc press conference, the Royal Australian College of General Practitioners' (RACGP) Tim Jones described the policy as "future-focused".
He also said he believed it would be "attractive" to new and interstate GPs.
"We are training a record number of GPs here in Tasmania, but those are doctors who do not have business experience, who are not clinic owners," he said.
"We think that working under this model is going to enable them to do what they do best, which is just focus on the care of their patients."
Rural Doctors Association of Tasmania president Ben Dodds was more reserved, saying it was "an interesting line for the state to cross".
"It's one that may lead to some perils in terms of the state learning how to own, operate and run general practices. It's an area that they don't have any experience in," he said.
"There's evidence of other jurisdictions doing it in areas of market failure [and] in rural and remote areas.
"In the context of TassieDocs, implementing this initiative where there might already be viable private General Practice does risk reorganising the doctors in the local community and not actually bringing any new services to Tasmania."
Dr Dodds said with the cost of running a general practice having increased significantly, the TassieDoc model might appeal to those doctors who were less interested in the business side of things.
"But the state government is going to be up for the cost of running the practice, which ultimately the taxpayer foots the bill for," he said.
"When local government steps in to run general practices, for example, in the Huon Valley with Geeveston and Dover, they're often run at a loss.
"Even though they're subsidised by the council, the overall practice loses money with higher bulk-billing rates, so it will be a very costly exercise for the state government."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

News.com.au
13 minutes ago
- News.com.au
‘Screw over': Truth about Donald Trump's plan to impose crippling 200 per cent tariffs on Australian pharmaceuticals
US President Donald Trump's plan to drop a 200 per cent tariff bomb on Australian pharmaceuticals is set to 'screw over' the sickest and most vulnerable in the United States suffering rare and life-threatening conditions including burns patients. As the Albanese Government scrambles to secure more information about the US government's latest plans, Australian officials are sounding the alarm given that pharmaceutical exports are worth over $2 billion a year. All plasma products collected in Australia stay here and are not exported to the US. Instead, the export issue relates to vaccines and blood products collected overseas and sent to Australia for processing before being returned to the US. President Donald Trump has threatened to introduce 200 per cent tariffs on pharmaceuticals – one of Australia's biggest exports to the US. Speaking to the media before a cabinet meeting, the President suggested the 'very, very high' levies on pharmaceuticals would not go into effect immediately, saying he would give drug manufacturers 'about a year, year and a half' to respond and relocate their operations to the US. 'They're going to be tariffs at a very high rate, like 200 per cent,' Mr Trump told reporters. 'We'll give them a certain period of time to get their act together,' he added, seemingly referring to drug manufacturers bringing back manufacturing into the US. Australia is subject to a 10 per cent 'baseline' tariff, which was the minimum rate imposed on all US trading partners by Mr Trump earlier this year. Australia's plasma exports to the US One of the biggest sections of the market includes blood products such as plasma products including exports linked to CSL Plasma which collects blood plasma in the United States. In 2023, Australia exported $1.42 billion of vaccines, blood, antisera, toxins and cultures, making it the 20th largest exporter of 208 in the world. Blood collection is a commercial operation in the United States, with plasma donors typically paid for their blood. CSL Plasma operates one of the world's largest and most sophisticated plasma collection networks, with nearly 350 plasma collection centers in the US and elsewhere. The blood products are mostly processed in the US but some are sent back to Australia to manufacture therapies for a variety of rare and life-threatening conditions. These conditions include primary immunodeficiencies, bleeding disorders like hemophilia, neurological disorders, and critical care needs like those arising from trauma or burns. One Australian official predicted that demand for the products would continue but the tariffs would 'screw over' patients relying on the notorious US healthcare system. Vulnerable patients will be hit with cost increases because the tariffs are paid by importers, not Australian exporters. CSL has a factory in Melbourne Biotech giant CSL has a plasma fractionation facility in Broadmeadows in Melbourne. The impact of the threatened tariffs relates to the commercial arm of CSL. which uses US blood products which are sourced in America and then processed in Australia before being sent back. 'Plasma manufacturing is a really fragile supply chain because it starts in a human vein,'' an industry source said. 'It's not a tap that you can turn on or off. You need people to vote with their feet to go into a facility that is enabled to collect plasma, and the demand for plasma products is growing globally each year.' 'Tariffs on pharmaceuticals impact the end user.' Treasurer Jim Chalmers 'very concerned' The Treasurer said on Wednesday that Washington's latest announcement was 'very concerning'. 'These are obviously very concerning developments,' Mr Chalmers told the ABC, adding that it had 'been a feature of recent months that we've had these sorts of announcements out of DC'. 'It's still early days. Obviously, we'll make a more detailed assessment of what's come out of the US in the usual way.' 'Our pharmaceuticals industry is much more exposed to the US market, and that's why we're seeking - urgently seeking - some more detail on what's been announced. 'But I want to make it really clear once again … our Pharmaceutical Benefit Scheme is not something that we're willing to trade away or do deals on – that won't change.' 'We've made it very clear that we think these tariffs are bad for the US, bad for Australia and bad for the global economy.' Mr Chalmers said one of the things the Albanese Government was 'most concerned' about was in addition to the direct impact on Australian workers and industries caused by this tariff, was the 'impact on global demand more broadly'. 'That's why we've been … at every opportunity, making the case that these tariffs are unjustified, they should be removed in line with our free trade agreement,' he said. The Prime Minister has described the taxes on Australian exports to the US as an 'act of economic self-harm'. 'Tariffs are a penalty on the country that is imposing them, because what they require is for goods to be purchased with a tax on top, and the US has made that decision,' the Prime Minister said. How plasma exports are used to help patients CSL Behring uses a process called plasma fractionation to separate the collected plasma into different components, such as immunoglobulins, coagulation factors, and other proteins. One example is helping people with bleeding disorders, with doctors utilising coagulation factors that are used to help patients with hemophilia and other bleeding disorders. Plasma-derived products are also used in emergency situations like severe trauma, burns, and shock to replace lost blood volume and proteins. For now, Australian officials concerned about the impact on blood product exports don't have full clarity on how it will impact the supply chain process.

ABC News
an hour ago
- ABC News
How often should you check in with your doctor about your contraceptive pill?
Stephanie Jenkins was 18 years old when she was prescribed a hormonal contraception tablet to help her with acne. The now-32-year-old from Kabi Kabi land on the Sunshine Coast took the same medication for a decade before she started experiencing debilitating migraines. "They were aura migraines, so disturbances in vision, light sensitivity, I couldn't see out of my right eye properly," she says. After having her symptoms dismissed by a GP, Stephanie saw another doctor through an online prescription renewal service. "As soon as I told her all of the symptoms and how often it had been occurring … she just point blank said, 'you immediately need to cease [the pill you are on]'," she says. The doctor told Stephanie the migraines were an indicator of an 'oestrogen overload', a side-effect of the pill which heightens the risk of stroke. "I didn't even know it was because of the pill, I just thought it was related to my period. "You just get put on it, you take it … set and forget." Dr Phoebe Holdenson Kimura says generally, GP's should conduct a yearly review for repeat prescriptions. The lecturer at the University of Sydney's General Practice Clinical School says the key message is that taking hormonal contraception should not be "a set-and-forget process". "Finding out when it was started, what it was started for is important," Dr Holdenson Kimura says. "So, recognising many women take the combined contraceptive pill for contraception, but it also can be used for acne as well as for the management of heavy menstrual bleeding or painful periods. She says doctors should also be checking risk factors with patients, including if they have had lifestyle changes or had medical issues such as migraines, deep vein thrombosis, a pulmonary embolism, high blood pressure, or have liver disease. Dr Eveline Mu is a research fellow at Monash University's HER Centre in Naarm/Melbourne and says there needs to be greater awareness at GP-patient consultations of the risks of depressive disorders. She has been studying the neurological impacts of hormonal contraceptive medication on women's moods. "We've found that there are certain types of common hormone contraception that will be worse for women who are susceptible to mood disorders or who have mood disorders," Dr Mu says. "Fluctuation or any differences in the oestrogen level can impact a lot of other neurotransmitters like serotonin or dopamine which are linked to mood and involved in emotion processing as well." Dr Pav Nanayakkara, a minimally invasive gynaecological surgeon from Jean Hailes for Women's Health, says along with a yearly consult there are other life milestones that should prompt a contraceptive medication check-in. "Any sort of significant life change — so pregnancy, around the time of perimenopause, any diagnosed medical conditions, any lifestyle changes," she says. "Because lifestyle factors can change as we age, we might have different requirements, or we might develop medical conditions." Research conducted by the Jean Hailes for Women's Health shows that just over half of the 3,537 women it surveyed last year, aged 18 to 50 years, didn't know about the full range of contraceptive medications available to them. "This finding was even more significant in the 40-to-50-year age group," Dr Nanayakkara says. "[These women] are then often giving advice to their daughters and may not necessarily know about all of the options." Stephanie says her mother took the pill, so it seemed like the right thing to do at the time. "It was the only thing that was offered to me as an acne treatment which seems wild to me because now I'm more educated," she says. Stephanie says she now tracks her menstrual cycle and uses other contraceptive methods. Dr Holdenson Kimura says it is also important to get advice from your doctor and not social media. "I'm having a lot more women coming in saying 'I want to talk about going off the pill' or, 'I've made the decision to go off the pill because I'm curious to know what it feels like'," she says. "I think that's fine … but equally it is important to be having those conversations [with their GP] about what to consider. "Especially if the pill's been managing heavy periods or painful periods and women want to come off it then we really need to look at what are the other options to help you with that." This is general information only. For detailed personal advice, you should see a qualified medical practitioner who knows your medical history.

ABC News
5 hours ago
- ABC News
Symerien Brooking's death at Perth Children's Hospital to be examined at coronial inquest
A coronial inquest into the death of a 10-year-old girl who died at WA's main paediatric hospital last August is set to take place after her mother shared her story, and her pleas for answers, with the ABC. WARNING: This story contains the name and image of an Indigenous person who has died. Sharyn Morris said she hoped the inquest would help her understand why her repeated requests for her daughter, Symerien Brooking, to have a brain scan were ignored, and what caused the fatal bleeding on her daughter's brain. "I need answers. I need to know," she said. "I need to know why my child's life was taken unnecessarily. "And to know that it's not going to happen to other people. "There has to be justification for what goes wrong." Symerien was taken off life support almost 48 hours after arriving at Perth Children's Hospital (PCH). Ms Morris had found her daughter unresponsive on the floor. Symmie, as she had come to be known, was born with an extremely rare and complex congenital disease and lived with numerous medical conditions. She was under the care of several specialists at PCH, including within the neurology department, and had presented twice in the months before her death with seizure activity. As soon as the ambulance arrived at the hospital, Ms Morris said she asked those treating her daughter to organise a CT scan of Symmie's brain. While Symmie did go on to have seizures — with one lasting 45 minutes — Ms Morris said she was not seizing upon presentation, so should have been able to have a scan. Despite what Ms Morris said were repeated requests for her daughter to have a brain scan, one was not done until seven hours later. By then it was too late. The scan found significant bleeding, and while surgery was done to insert drains in an attempt to remove the fluid, it did not work. Ms Morris — who was herself a grandmother when she took over caring for Symmie when the girl was just 10 days old — left the hospital without the person who had become her whole world. The ABC first told the story of Symmie's remarkable life and Ms Morris's relentless pursuit of her daughter's survival in 2019. When Symmie was born, doctors did not expect her to live for much more than a year. But Symmie defied all the odds. Ms Morris said her daughter's prognosis had never been more positive and her overall care plan had gone from being one focused on providing quality of life to including quantity. One of Symmie's doctors had even told her he expected her daughter would outlive her. Ms Morris wants the inquest to not only understand what happened in her daughter's case, but to try and bring about cultural change within the medical system, so parents and caregivers are listened to by doctors. "She [Symmie] was a very caring, loving young girl, and she gave everything to all who met her," Ms Morris said. "I know that she would want to make sure that the system was better … so other children didn't suffer and other parents don't suffer." As a community advocate, Suresh Rajan has supported other families in their quests for answers after a child they loved died in WA's health system, including the 2021 death of Aishwarya Aswath at PCH, and Sandipan Dhar who died in March last year at Joondalup Health Campus. "If you look at all of the cases that we've had in the last few years, all of them boil down to one thing — that the medical professional is not listening to either the caregiver or the patient as to what is required," he said. Mr Rajan said he hoped an inquest into Symmie's death, alongside those into the deaths of Aishwarya and Sandipan, would bring about actual change. "I hope that these cases become seminal events in changing the culture of our health system," he said. "The WA health system suffers from a culture of doctors not listening to the patient or the caregiver, they have the view that they're the only ones who know what's wrong with that person. That has to change." While a date for the inquest is yet to be announced, the WA Coroner has advised one will take place, according to a government spokesperson. "This information was shared by the Health Minister with Ms Morris during their meeting last month," the spokesperson said. "The death of any child or young person is a tragedy, which has a devastating impact on the families, friends and communities involved.